We are forma
Established in 2016, Forma builds businesses in legal medical cannabis markets around the world. With offices in London and Los Angeles, we take an international view of the cannabis market, and operate in three areas
Retail and Cultivation
We have acquired a series of medical cannabis assets across cultivation, manufacturing and distribution in the Western United States. Construction on the first assets is complete, scheduled to open later this year.
Pharmaceutical and Life Sciences
We are designing research programs with world-renowned academic institutions into the medical properties of cannabis, with a view to ultimately initiating clinical trials and bringing new cannabinoid-based medicines to market.
We invest in ambitious entrepreneurs and iconic businesses shaping the cannabis industry. We drive value creation with our portfolio companies through our deep domain expertise, and operate on a no-fee basis for our investors.
We believe that legal cannabis markets will open up across the world as the medical benefits of cannabis become increasingly accepted.
We believe in the careful, responsible development of the cannabis market, with improved outcomes for patients, society and the environment central to everything that we do.
We believe that the most successful teams in the cannabis market will combine the passion and values of the cannabis advocacy movement with the rigor and professionalism of the corporate world.
The Forma team has decades of experience in management, cannabis operations, private equity and venture capital.
Gavin Sathianathan, CEO
Gavin focuses on building out the company across its divisions, in the US and internationally. He has 13 years’ experience across general management, marketing and technology. He was formerly the MD of Tesco’s Digital Entertainment business in the UK, and was one of the early appointments into Facebook EMEA.
Previously, Gavin was Head of Business Development at Endemol, and began his career at Bain and Company. Gavin holds an undergraduate degree in Chemical Engineering from Imperial College London and an MBA from Harvard Business School.
Tarek Tabsh, Chief Strategy Officer
As an entrepreneur and patient advocate, Tarek has unique and extensive experience building some of the earliest, legal enterprises to emerge in the US medical cannabis industry. Since 2006, he has launched numerous successful cannabis ventures and strategic partnerships. He is a member of the Coalition for Cannabis Policy Reform (CCPR), the International Association for Cannabinoid Medicines (IACM), and sits on the ArcView selection committee.
Tarek has won numerous cannabis industry awards, including three High Times Cannabis World Cups. As a graduate student, Tarek studied Innovation-Driven Entrepreneurship at the Massachusetts Institute of Technology’s Sloan School of Management, Harvard Business School, and the Harvard School of Engineering and Applied Sciences.
Neil Mahapatra, President
Neil is a partner at Kingsley Capital Partners, the UK investment firm that helped establish Forma. Previously, Neil was a private equity executive at RIT Capital Partners in London, having begun his career at Morgan Stanley. Neil holds an undergraduate degree in Biological Sciences from Oxford University and an MBA from Harvard Business School.
Hee-Dong Kim, Executive Director
Hee-Dong is a partner at Kingsley Capital Partners, the UK investment firm that helped establish Forma. He has previous experience as a private equity executive at Invision Private Equity, having begun his career at the Boston Consulting Group. Hee-Dong holds an undergraduate degree in Economics from the London School of Economics and an MBA from Harvard Business School.